DISHMAN CARBOGEN AMCIS
Back to Balance Sheet
|
DISHMAN CARBOGEN AMCIS Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹9,571 Cr | ₹9,439 Cr | ₹8,634 Cr | ₹8,356 Cr | ₹8,193 Cr |
What is the latest Total Liabilities ratio of DISHMAN CARBOGEN AMCIS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹9,571 Cr |
Mar2023 | ₹9,439 Cr |
Mar2022 | ₹8,634 Cr |
Mar2021 | ₹8,356 Cr |
Mar2020 | ₹8,193 Cr |
How is Total Liabilities of DISHMAN CARBOGEN AMCIS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹9,571 Cr | 1.39 | |
Mar2023 | ₹9,439 Cr | 9.33 | |
Mar2022 | ₹8,634 Cr | 3.33 | |
Mar2021 | ₹8,356 Cr | 1.98 | |
Mar2020 | ₹8,193 Cr | - |
Compare Total Liabilities of peers of DISHMAN CARBOGEN AMCIS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DISHMAN CARBOGEN AMCIS | ₹3,944.3 Cr | 4.2% | -5.5% | 43.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,320.0 Cr | 0.9% | -0.1% | 10.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,823.0 Cr | 3.7% | 3% | 46.5% | Stock Analytics | |
CIPLA | ₹121,591.0 Cr | 0.2% | 2.8% | 1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,400.0 Cr | 7.3% | 7.4% | 19.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,135.0 Cr | -4% | 2.6% | 7.2% | Stock Analytics |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DISHMAN CARBOGEN AMCIS | 4.2% |
-5.5% |
43.3% |
SENSEX | 2.1% |
2.4% |
7.1% |
You may also like the below Video Courses